Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-05-09 Bridger Gary Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2016-03-16 BAKER BROS. ADVISORS LP 10% owner Purchase +1,289 $7.70 $10K 790,130
2016-03-16 BAKER BROS. ADVISORS LP 10% owner Purchase +11,840 $7.70 $91K 6,613,731
2016-03-16 BAKER BROS. ADVISORS LP 10% owner Purchase +20,192 $7.91 $160K 810,322
2016-03-16 BAKER BROS. ADVISORS LP 10% owner Purchase +185,413 $7.91 $1.5M 6,799,144
2016-03-16 BAKER BROS. ADVISORS LP 10% owner Purchase +14,046 $8.16 $115K 824,368
2016-03-16 BAKER BROS. ADVISORS LP 10% owner Purchase +128,975 $8.16 $1.1M 6,928,119
2016-03-15 BAKER BROS. ADVISORS LP 10% owner Purchase +3,374 $7.88 $27K 781,421
2016-03-15 BAKER BROS. ADVISORS LP 10% owner Purchase +30,986 $7.88 $244K 6,533,759
2016-03-15 BAKER BROS. ADVISORS LP 10% owner Purchase +7,420 $8.03 $60K 788,841
2016-03-15 BAKER BROS. ADVISORS LP 10% owner Purchase +68,132 $8.03 $547K 6,601,891
2016-03-10 SHREWSBURY STEPHEN B CMO; Senior VP Clinical Dev. Grant or award · Stock Option (Right to Buy) +35,000 35,000
2016-03-10 Mitchell David Chilton VP Global Regulatory & Quality Grant or award · Stock Option (Right to Buy) +25,000 25,000
2016-03-10 Main David President and CEO Grant or award · Stock Option (Right to Buy) +120,000 120,000
2016-03-10 MacKenzie Lloyd VP Technical Operations Grant or award · Stock Option (Right to Buy) +35,000 35,000
2016-03-10 Alam Kamran CFO, Vice President Finance Grant or award · Stock Option (Right to Buy) +40,000 40,000
2016-01-26 BAKER BROS. ADVISORS LP 10% owner Purchase +7,318 $10.80 $79K 777,652
2016-01-26 BAKER BROS. ADVISORS LP 10% owner Purchase +66,345 $10.80 $717K 6,499,192
2016-01-26 BAKER BROS. ADVISORS LP 10% owner Purchase +395 $11.00 $4K 778,047
2016-01-26 BAKER BROS. ADVISORS LP 10% owner Purchase +3,581 $11.00 $39K 6,502,773

Page 17 of 20 · 397 trades